Digestive & Intestinal Remedies (Pharmacies) - Eastern Europe

  • Eastern Europe
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$1.69bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.84%, resulting in a market volume of US$2.04bn by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$7.08 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Eastern Europe is experiencing significant growth and development. Customer preferences in the region are shifting towards natural and herbal remedies for digestive and intestinal issues. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more sustainable. This trend is driven by a growing awareness of the potential side effects of traditional pharmaceuticals and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for natural remedies such as herbal teas, probiotics, and dietary supplements that promote digestive health. Trends in the market indicate a growing emphasis on preventive healthcare and self-care. Consumers are taking a proactive approach to managing their digestive and intestinal health, seeking products that can help prevent issues rather than just treating symptoms. This has led to an increase in the sales of preventive products such as probiotics and dietary supplements that support gut health. Additionally, there is a growing interest in functional foods and beverages that offer digestive benefits, such as fiber-rich products and fermented foods. Local special circumstances in Eastern Europe contribute to the development of the Digestive & Intestinal Remedies market. The region has a rich tradition of herbal medicine and natural remedies, which aligns with the current consumer preferences for natural products. This cultural heritage has fostered a strong market for herbal remedies and alternative therapies. Additionally, the relatively high prevalence of digestive and intestinal issues in Eastern Europe, due to factors such as diet and lifestyle, has created a strong demand for products that address these specific health concerns. Underlying macroeconomic factors also play a role in the growth of the Digestive & Intestinal Remedies market in Eastern Europe. The region has been experiencing steady economic growth, leading to an increase in disposable incomes and consumer spending power. This has allowed consumers to prioritize their health and wellness, leading to increased spending on healthcare products, including digestive and intestinal remedies. Furthermore, the aging population in Eastern Europe is driving the demand for products that address age-related digestive issues, such as constipation and indigestion. In conclusion, the Digestive & Intestinal Remedies market in Eastern Europe is developing due to changing customer preferences, a focus on preventive healthcare, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the emphasis on preventive healthcare, the cultural heritage of herbal medicine, and the increasing disposable incomes all contribute to the growth and development of the market in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)